Shanxi Zhendong Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Shanxi Zhendong Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Shanxi Zhendong Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Productive biological assets1,645,3873.0E-4432015-06-30historic
Selling expenses287,884,9560.05317472015-06-30historic
Estimated liabilities31,670,0000.00585722015-06-30historic
Goodwill193,717,1200.035781172015-06-30historic
Cash paid for other financing activities87,995,7970.016251432015-06-30historic
Long term accounts payable46,250,0000.008541652015-06-30historic
Capital reserve1,277,760,7850.235991672015-06-30historic
Diluted eps00.01932015-06-30historic
Intangible assets291,263,8420.053791982015-06-30historic
Other receivables89,640,7720.016562502015-06-30historic
Non-operating loss1,807,5613.3E-42542015-06-30historic
Prepayment136,286,5350.025172722015-06-30historic
Interest receivable738,5271.4E-42842015-06-30historic
Fixed assets1,000,397,7870.184773372015-06-30historic
Payroll payable28,064,2900.005183382015-06-30historic
Cash paid for taxes80,229,2520.014823672015-06-30historic
Net cash flows from investing activities-13,293,126-0.002463892015-06-30historic
Total cost of goods sold975,299,8110.180134002015-06-30historic
Other payables100,274,2700.018524112015-06-30historic
Total non-current assets1,646,405,6110.304084212015-06-30historic
Revenue998,685,2440.184454292015-06-30historic
Short term borrowings415,000,0000.076654292015-06-30historic
Cash outflows from operating activities992,901,9250.183384542015-06-30historic
Deferred tax assets18,681,1170.003454682015-06-30historic
Cash inflows from operating activities970,246,6760.17924802015-06-30historic
Accounts payable271,953,2780.050234972015-06-30historic
Net change in cash26,719,2680.004935252015-06-30historic
Net cashflow from financing activities62,667,6420.011575422015-06-30historic
Total liabilities and equity3,147,231,0550.581275522015-06-30historic
Financial expenses10,818,1790.0025682015-06-30historic
Interests payable678,2071.3E-45722015-06-30historic
Inventories327,467,7570.060485832015-06-30historic
Notes receivable26,161,1340.004835872015-06-30historic
Cash inflows from financing activities384,932,9560.071095882015-06-30historic
Total liabilities1,171,950,7150.216455942015-06-30historic
Other current assets10,106,7630.001877692015-06-30historic
Minority interest12,857,3050.002377932015-06-30historic
Total profit36,567,4980.006758032015-06-30historic
Net cash and cash equivalents ending balance222,168,1310.041038112015-06-30historic
Net income28,828,8750.005328122015-06-30historic
Total comprehensive income28,828,8750.005328152015-06-30historic
Operating profit23,385,4330.004328712015-06-30historic
Purchases of fixed assets and others13,293,1260.002469842015-06-30historic
Comprehensive income attributable to minority shareholders-3,297,225-6.1E-49842015-06-30historic
Minority interests gain-3,297,225-6.1E-49992015-06-30historic
Cash paid for dividends, profits or interests11,269,5170.0020810292015-06-30historic